Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).

ABSTRACT:

SUBMITTER: Chanan-Khan A 

PROVIDER: S-EPMC5420789 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature